Balanced news tone
News Sentiment
BRM sentiment intelligence
Bristol-Myers Squibb Company news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
Weighted score
49
Balanced news tone
10 relevant articles
News tone and price action are not far from neutral.
84/100 classification confidence.
directly relevant articles
high-authority source matches
-2.9% over one week, -6.5% over four weeks, trend active, and near fair-value range.
Bristol-Myers Squibb Company stock (US0897961004): options activity spikes as new cancer trial data
Market Reaction
Balanced read
News tone and price action are not far from neutral.
Primary event
Market update
84/100 classification
One-week reaction
-2.9%
Price reacting lower
Trend fit
Trend active
-6.5% over four weeks
Fair value
9.1%
Near fair-value range
Sentiment Mix
Positive, neutral, negative
Positive
1
Neutral
8
Negative
1
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
Above 50
Neutral zone
Below 50
News Tape
Relevant headlines
AD HOC NEWS
Direct company coverage
Bristol-Myers Squibb Company stock (US0897961004): options activity spikes as new cancer trial data
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 03 Jun 2026 07:00
- Source
- AD HOC NEWS
AD HOC NEWS
Direct company coverage
Bristol-Myers Squibb Company stock (US0897961004): EU label expansion for Opdivo follows solid Q1 ea
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 02 Jun 2026 07:00
- Source
- AD HOC NEWS
AD HOC NEWS
Direct company coverage
Bristol-Myers Squibb Company stock (US0897961004): ASCO 2026 mezigdomide data in focus after Phase 3
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 30 May 2026 07:00
- Source
- AD HOC NEWS
AD HOC NEWS
Direct company coverage
Bristol Myers Squibb stock (US1101221083): steady NYSE pricing ahead of next catalysts
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 29 May 2026 07:00
- Source
- AD HOC NEWS
AD HOC NEWS
Direct company coverage
Bristol-Myers Squibb Company stock (US0897961004): Shares ease ahead of Goldman Sachs healthcare con
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 28 May 2026 07:00
- Source
- AD HOC NEWS
CNBC
Direct company coverage
Bristol Myers Squibb turns to China to develop new drugs in newest cross-continent collaboration
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 15 May 2026 07:00
- Source
- CNBC
Seeking Alpha
Direct company coverage
Bristol Myers Squibb: Strong Pipeline, Weak Outlook (Rating Downgrade)
- Tone
- Negative 34/100
- Event
- Guidance
- Published
- 24 Apr 2026 07:00
- Source
- Seeking Alpha
IndexBox
Direct company coverage
Bristol Myers Squibb: Value Stock Analysis for Dividend Investors in 2026 - News and Statistics
- Tone
- Neutral 50/100
- Event
- Capital return
- Published
- 13 Apr 2026 07:00
- Source
- IndexBox
IndexBox
Direct company coverage
Bristol Myers Squibb: A Defensive Dividend Stock for Volatile Markets - News and Statistics
- Tone
- Neutral 50/100
- Event
- Capital return
- Published
- 21 Mar 2026 07:00
- Source
- IndexBox
Investopedia
Direct company coverage
BioNTech Stock Jumps on Bristol Myers Squibb Cancer Drug Collaboration
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 02 Jun 2025 07:00
- Source
- Investopedia